Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 4
1953 2
1955 2
1956 2
1957 1
1958 2
1959 2
1960 2
1962 2
1963 2
1964 1
1965 9
1966 5
1967 4
1968 9
1969 9
1970 5
1971 6
1972 3
1973 4
1974 6
1975 5
1976 7
1977 19
1978 14
1979 13
1980 10
1981 16
1982 29
1983 20
1984 22
1985 13
1986 14
1987 32
1988 22
1989 14
1990 26
1991 13
1992 10
1993 21
1994 27
1995 17
1996 14
1997 22
1998 27
1999 25
2000 24
2001 23
2002 25
2003 39
2004 50
2005 58
2006 42
2007 62
2008 45
2009 74
2010 67
2011 69
2012 63
2013 62
2014 77
2015 66
2016 65
2017 80
2018 57
2019 73
2020 94
2021 71
2022 37
Text availability
Article attribute
Article type
Publication date

Search Results

1,699 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.
Motozono C, Toyoda M, Zahradnik J, Saito A, Nasser H, Tan TS, Ngare I, Kimura I, Uriu K, Kosugi Y, Yue Y, Shimizu R, Ito J, Torii S, Yonekawa A, Shimono N, Nagasaki Y, Minami R, Toya T, Sekiya N, Fukuhara T, Matsuura Y, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium, Ikeda T, Nakagawa S, Ueno T, Sato K. Motozono C, et al. Among authors: ito j. Cell Host Microbe. 2021 Jul 14;29(7):1124-1136.e11. doi: 10.1016/j.chom.2021.06.006. Epub 2021 Jun 15. Cell Host Microbe. 2021. PMID: 34171266 Free PMC article.
International consensus (ICON) on treatment of sudden sensorineural hearing loss.
Marx M, Younes E, Chandrasekhar SS, Ito J, Plontke S, O'Leary S, Sterkers O. Marx M, et al. Among authors: ito j. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S23-S28. doi: 10.1016/j.anorl.2017.12.011. Epub 2018 Feb 1. Eur Ann Otorhinolaryngol Head Neck Dis. 2018. PMID: 29396226 Free article.
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S, Fukuhara T, Sato K. Suzuki R, et al. Among authors: ito j. Nature. 2022 Mar;603(7902):700-705. doi: 10.1038/s41586-022-04462-1. Epub 2022 Feb 1. Nature. 2022. PMID: 35104835 Free PMC article.
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C. Baden LR, et al. Among authors: ito ji. J Natl Compr Canc Netw. 2016 Jul;14(7):882-913. doi: 10.6004/jnccn.2016.0093. J Natl Compr Canc Netw. 2016. PMID: 27407129
Bereavement After a Child's Death.
Jonas D, Scanlon C, Rusch R, Ito J, Joselow M. Jonas D, et al. Among authors: ito j. Child Adolesc Psychiatr Clin N Am. 2018 Oct;27(4):579-590. doi: 10.1016/j.chc.2018.05.010. Epub 2018 Jun 27. Child Adolesc Psychiatr Clin N Am. 2018. PMID: 30219219
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M; Genotype to Phenotype Japan (G2P-Japan) Consortium, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K. Saito A, et al. Among authors: ito j. Nature. 2022 Feb;602(7896):300-306. doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25. Nature. 2022. PMID: 34823256 Free PMC article.
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
Kato Y, Tabata K, Kimura T, Yachie-Kinoshita A, Ozawa Y, Yamada K, Ito J, Tachino S, Hori Y, Matsuki M, Matsuoka Y, Ghosh S, Kitano H, Nomoto K, Matsui J, Funahashi Y. Kato Y, et al. Among authors: ito j. PLoS One. 2019 Feb 27;14(2):e0212513. doi: 10.1371/journal.pone.0212513. eCollection 2019. PLoS One. 2019. PMID: 30811474 Free PMC article.
1,699 results